The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure is a research paper published in Cardiovascular Research (2021). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Una forma de hacer Europa
Grant: PI18/01231
Una forma de hacer Europa
Grant: PI18/01582
La Fe Biobank
Grant: PT17/0015/0043
Lung and Blood Institute (NHLBI
Grant: 1R01HL132401
Lung and Blood Institute (NHLBI
Grant: R01HL151737
Lung and Blood Institute (NHLBI
Grant: NIH (S10 OD018135)
Leducq Foundation
Grant: 14 CVD 03
NIA
Grant: R21AG060413-01
FWCI
3.79
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals